About
Andrew Gilbert leads DLA Piper’s US Corporate practice and co-chairs the Life Sciences sector globally. He focuses on corporate matters including M&A, venture capital, public company governance, capital markets, private equity, energy, life sciences, and technology.
Practice areas
CorporateMergers and AcquisitionsEmerging Growth and Venture CapitalPublic Company and Corporate GovernanceCapital MarketsPrivate EquityEnergy and Natural ResourcesLife SciencesTechnology
Office
Expertise
Corporate lawMergers and AcquisitionsEmerging Growth and Venture CapitalPublic Company and Corporate GovernanceCapital MarketsPrivate EquityEnergy and Natural ResourcesLife SciencesTechnology
Languages
English